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Advances in stereotactic and functional neurosurgical techniques have brought about new developments in the
surgical treatment for Parkinson's disease, including methods such as ablative therapy, chronic brain stimulation,
stereotactic radiosurgery and transplantation. Significant benefits can be provided for patients who have become
refractory to medical therapy or developed adverse side-effects after prolonged administration of levodopa. (HK
Pract 1999;21:106-115)
Introduction
Parkinson's disease (PD) is a
common neurological problem. The
local prevalence of PD is unknown.
Although it has been estimated that
around 2,500 patients are affected in
Hong Kong, the actual figure is likely
to be considerably higher.1 At
present, there is no cure for PD and
its treatments aim at symptomatic
relief. Surgical treatment for PD was
first developed in 1950's but it fell
out of favour with the introduction of
levodopa in 1960's. It was soon
realized, however, that although
levodopa is the most efficacious form
of treatment, it is not the permanent
answer to PD. As the disease
progresses and w i t h prolonged
levodopa administration, symptoms
become refractory to the drug.
Patients require an increasing dosage
while being at risks of developing
a b r u p t "on-off" episodes and
d i sab l ing s ide-ef fec ts such as
dyskinesia (involuntary movements).
With advance in stereotactic and
functional neurosurgical techniques,
there has been resurgent interest and
rapid developments in the surgical
treatment for PD over the last two
decades.
The aim of surgery is to improve
function by abolishing the symptoms
(e.g. tremor, bradykinesia, rigidity)
without incurring added neurological
deficit. Patient selection and the
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choice of procedure are of paramount
importance in determining treatment
success. In general , surgery is
ind ica ted if the symptoms are
d i s a b l i n g and p e r s i s t e n t a f t e r
adequate trial with medical therapy.
M e d i c a l t h e r a p y and s u r g i c a l
treatment, however, are by no means
m u t u a l l y e x c l u s i v e . Indeed ,
previously effect ive control by
levodopa may indicate good response
to surgery and many patients continue
to require some form of d rug
treatments after surgery, albeit post-
ope ra t ive r educ t ion in dosage
requirement and drug-related side-
effects, and improvement in PD
symptoms. Major contraindications
t o s u r g e r y i n c l u d e d e m e n t i a ,
uncontrolled hypertension, bleeding
disorders, and "atypical" parkinso-
n i a n syndromes , which do not
respond well to surgery. Old age is
not a contraindication per se but is
associated with increased surgical
risks. Table 1 lists the available
surgical methods for the treatment of
PD. A multidisciplinary approach is
essential and involves contribution
from the neurosurgeon, neurologist,
neuroradiologist, neurophysiologist,
neuropsychologist and a rehabilita-
tion team.
Pathophysiology
Although the pathogenesis of
most movement disorders is poorly
understood, it is now widely accepted
that PD results from the loss of
d o p a m i n e r g i c n e u r o n e s a n d
subsequent dysfunction within the
basal ganglion, which is responsible
for the initiation, maintenance, and
modulation of voluntary movement.
Figure 1 gives a modified schematic
representation of the basal ganglia-
thalamocortical motor circuit. The
latter is essentially a re-entrant
pathway through which signals from
the motor cortex (e.g. 'to move') are
processed within the basal ganglion
and thalamus, and then returned to
the motor cortex. The str iatum,
composed of the caudate nucleus and
the putamen, receives input from the
motor cortex. The globus pallidus
interna (GPi) and substantia nigra
reticulata (SNr) complex acts as the
output station of the basal ganglion.
The 'direct' and 'indirect' pathways
function respectively as positive and
negative feed-back loops which
r e g u l a t e t h e t h a l a m o c o r t i c a l
ac t iv i t ies . In PD, reduct ion in
dopaminergic activities results in loss
of inh ib i t ion from the 'd i rec t '
pathway and increased stimulation
Table 1: Surgical methods for the treatment of Parkinson's disease
Ablative
stimulation; - Thalamic stimulation
'.''• - Pallidal stimulation
','':'- . :: - Subthalamic nucleus stimulation




nigra compacta : GPe = glodus pallidus externa
SNr = substantia nigra reticulata GPi = glodus pallidus interna
STN = subthalamic nucleus
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from the 'indirect' pathway to the
GPi/SNr complex. The net effect is
increased inhibition from GPi/SNr to
the thalamocortical pathway, causing
the classic hypokinetic symptoms of
akinesia (poverty of movement),
bradykinesia (slowness of movement)
and rigidity (lead-pipe or cog-wheel
types) seen in PD. Conversely,
hyperk ine t i c symptoms such as
levodopa-induced dyskinesia may
arise from reduced inhibition from
the GPi/SNr complex.2 Interestingly,
both hyperkinetic and hypokinetic
symptoms can coexist clinically,
i nd i ca t i ng that more complex
mechan i sm is at work . The
mechanism of tremor-production is
con t rove r s i a l but is p robab ly
associated with 'tremor-producing'
cells within the thalamus.
Ablative therapy
Principles and techniques
The strategy of ablative therapy
involves the use of stereotactic
technique and selective deep brain
lesioning to release the motor circuit
from abnormal activities described
above.3 A stereotactic head frame is
first mounted onto the patient's skull
under local anaesthetics. (Figure 2)
Imaging studies, using magnetic
resonance i m a g i n g (MRI) and
computerized tomography (CT), are
then carried out with the head frame
in-situ. The anterior and posterior
commissure (AC-PC) line, which
runs along the longitudinal axis of the
th i rd ven t r ic le , acts as the most
important reference landmark, and
with the aid of computer software
and brain atlas, the appropriate target
can be localized in Cartesian (x,y,z)
co-ordinates with respect to the head
Figure 2: A stereotactic frame is mounted onto the
patient's skull with pins
Figure 3: Mid-sagittal MRI image (Tl-weighted) showing
the anterior commissure-posterior commissure
(AC-PC) line
frame. (Figure 3) The patient is then
transferred to the operating room,
where, under local anaesthesia, a burr
hole is made in the patient's skull
t h r o u g h w h i c h a r e c o r d i n g /
stimulation electrode can be inserted
towards the intended target under the
guidance of the stereotactic frame.
Target localization is confirmed
a n d r e f i n e d u s i n g e l e c t r o -
physiological methods. (Figure 4)
For example, an electrode tip placed
within the ventralis caudalis (Vc)
nucleus of the ventrolateral thalamus
(Continued on page 110)
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will record activities in response to
contralateral fine touch s t imul i ,
whereas w i t h i n t h e v e n t r a l i s
intermedius (Vim) nucleus, tremor
frequency discharges or response to
contralateral proprioceptive stimuli
can be observed. When stimulation
is appl ied , a cor rec t ly placed
electrode within the Vim will either
drive or abolish tremor, depending on
the stimulating frequency, whereas
stimulation within or near the internal
capsule will result in movements of
the contralateral limbs.4 As the
patient remains awake throughout the
procedure, the surgeon can check for
therapeutic effects (e.g. tremor arrest)
as well as unwanted side-effects (e.g.
dysarthria, paraesthesia) during test
stimulation. The aim is not only to
locate the best lesioning target for the
maximal clinical benefit but also to
ensure that nearby structures with
crucial functions are not damaged.
Once the target is confirmed,
ablation is achieved with the use of
r a d i o f r e q u e n c y (RF) l e s ion ing
technique. With a specially designed
RF generator, the appropriate choice
of probe, lesioning temperature and
duration, a lesion of highly controlled
size and shape can be made. (Figure
5) A test lesion is made first. If the
effects are desirable, a permanent
lesion is then made, repeatedly if
necessary. Irreversible neuronal
ablation u sua l l y occurs with a
lesioning temperature of 75°C for 60
to 90 seconds. After the procedure,
the patient initially resumes the pre-
operative medications and can be
discharged wi th in a few days . 5
Diligent and long-term follow-up is
essent ial , ideally by the same
mult idiscipl inary team mentioned
above.
Figure 4: Structures of the right ventrolateral thalamus and basal




















The optic tract and STN
(dotted lines) lies ventral
to the other structures
Figure 5: Post-operative axial CT image showing a left
thalamotomy lesion
Thalamotomy
The lesioning target in thalamo-
tomy is the ventralis intermedius
(Vim) nucleus of the ventrolateral
thalamus. Thalamotomy can improve
contralateral tremor in 86% of PD
patients. Rigidity and bradykinesia
in general respond poorly.6 Most
(Continued on page 112)
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patients experience s i g n i f i c a n t
functional improvement although the
effect may decrease with time due to
disease progres-s ion. 7 General
mortality (0.5 to 1%) and morbidity
( 2 - 5 % ) i s l o w . S p e c i f i c
complications include contralateral
paraesthesia and weakness due to
damages to the Vc or internal capsule
respectively. Dysarthria and memory
d e f i c i t may be t r a n s i e n t o r
p e r m a n e n t . D a m a g e t o t h e
subthalamic nucleus may result in
hemiba l l i sm , a form of v io l en t
involuntary proximal limb movement.
For the same reason, lesioning is not
performed at the STN as a form of
a b l a t i v e t h e r a p y . The r i s k of
developing post-operative deficits is
i nc rea sed i n e l d e r l y p a t i e n t s .
B i l a t e r a l l e s i o n i n g s a r e a l so
associated with significant morbidity
and is generally not advocated. For
patients with bi la tera l symptoms,
unilateral procedures may sometimes
benefit the ipsilateral side, albeit to a
lesser extent than the contralateral
side.
Pallidotomy
Pallidotomy is indicated if the
p a t i e n t has p r e v i o u s l y showed
response to L-dopa but has subse-
quent ly developed in t r ac t ab i l i t y . 8
The best target is the most posterior
and ventral part of the GPi. Contrary
t o t h a l a m o t o m y , p a l l i d o t o m y
improves mainly bradykinesia and
rigidity with shortening of the 'off
periods (92% of patients). Levo-dopa
induced dyskinesia is also reduced.
Tremor, on the o ther h a n d , is
re la t ive ly less affected (81%) . 3
Overall improvement in motor and
activities of daily l i v i n g can be
achieved in 70 to 84% of patients.9
Specific complications include injury
to the in t e rna l capsu le caus ing
contralateral weakness. Injury to the
optic tract, which lies ventral to GPi,
may result in central visual field
defect.
Chronic deep brain stimula-
tion
Principles and techniques
It has long been realized that
high frequency stimulation (> 100 Hz)
at Vim can arrest tremor and that
st imulat ion can give rise to s imilar
behav ioura l effects as l e s i o n i n g .
Although its physiological basis is
s t i l l unknown, chronic deep brain
s t imula t ion has developed as an
alternative to ablative therapy over
the recent years. It uses the same
target localization principle as for
lesioning. But instead of causing a
lesion, a s t imulat ion probe is left
permanent ly i n - s i t u a f te r target
localization and an electrical lead is
brought out and connected to an
external stimulator. A period of post-
operative test stimulation is carried
out in order to assess the clinical
effects and determine the optimal
stimulation parameters. If clinical
improvemen t s can be o b t a i n e d
without unwanted side-effects, the
electrical lead is then internalized
and connected to a permanent and
programmable stimulation generator
implanted subcutaneously over the
infraclavicular area. This internal
generator is powered by a battery
which has to be changed every 3 to
4 years. Based on clinical assess-
ment, the stimulation parameters can
be further adjusted using an external
magnetic device.10
The advantage of chronic deep
b r a i n s t i m u l a t i o n i s t h a t a n y
unwanted side-effects can be readily
reversed by ad ju s t i ng or s imply
switching off the stimulation. The
parameters can be changed according
to disease progression and the
t echn ique does not exclude the
p a t i e n t s f r om r e c e i v i n g other
t h e r a p e u t i c i n t e r v e n t i o n (e.g.
t ransplanta t ion) . In contrast, the
effect of ablative therapy is "one-off
and i r revers ible . The main dis-
advantages of chronic st imulation
include the risks of infection and
migration of the implant. There is
also considerable added cost for the
device and demand for long-term
t e c h n i c a l s u p p o r t a n d p a t i e n t
compliance.
Thalamic stimulation
Similar to thalamotomy, chronic
tha lamic s t imu la t i on at the Vim
improves mainly contralateral tremor
(83%) whereas other PD symptoms
are less affected. There is minimal
permanent morbidity although around
one t h i r d of the p a t i e n t s may
e x p e r i e n c e s o m e t r a n s i e n t
neurological deficits.11-12 In patients
w h o h a v e a l r e a d y r e c e i v e d
thalamotomy on one side but who
also r e q u i r e t r e a t m e n t on the
contralateral side, chronic thalamic
stimulation can be considered as a
safer a l t e r n a t i v e to l es ion ing ,
especially in the elderly.
Pallidal stimulation
E x p e r i e n c e w i t h c h r o n i c
stimulation at the globus pallidus is
still limited.13-15 Initial results have
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demonstrated up to 70% improve-
ment in motor functions. Unlike
pal l idotomy, both contrala teral
akinetic symptoms as well as tremor
can be improved. The patients are
often able to reduce their levodopa
dosage which may at least partially
a c c o u n t f o r t he r e d u c t i o n i n
dyskines ia . Again , b i la tera l
procedure are associated with lower




Exper imenta l an imal studies
have shown that l es ion ing at the
sub tha lamic nuc leus (STN) can
relieve parkinsonian symptoms.16
Theoret ical ly , the STN is more
attractive than other aforementioned
targets in terms of neuronal circuitry
because of its multiple connections
within and beyond the basal ganglion.
Intervention at this site may therefore
exert a more wide-spread effect.
Indeed, chronic stimulation of the
STN has been found to produce
significant improvement in most PD
symptoms including gait, speech and
p o s t u r e . 1 5 , 1 7 These las t three
symptoms are often refractory to
ablative or stimulatory treatment at
other targets. The procedure is
relatively free of side-effects, except
h e m i b a l l i s m , which is u sua l l y
r e v e r s i b l e b y c h a n g i n g t h e
stimulation parameters while still




gamma-knife , is an al ternat ive
method of achieving selective deep
brain ab la t ion . The technique
involves similar Stereotactic principle
as in the open technique. Lesioning
is achieved by means of highly
f o c u s e d g a m m a i r r a d i a t i o n .
However, unlike in open surgery,
radiosurgery does not allow electro-
physiological localization. Accurate
target localization is crucial for the
success of PD surgery. Since target
localization is much more dependent
on electrophysiological rather than
morphological means, there is much
concern about the re l iab i l i ty of
gamma-knife in the treatment of PD.
Moreover, the lesion size is less
predictable in radiosurgery than by
radiofrequency lesioning and the
clinical effects can not be assessed
until the lesion 'matures' around 3 to
4 months af ter the procedure .
Although early results had been
disappointing,18 a recent study which
employed more refined techniques
h a d d e m o n s t r a t e d s i g n i f i c a n t
improvement in tremor and levodopa
induced dyskinesia in around 86% of
patients.19 Morbidity was minimal
and post-operative imaging studies of
the lesions had shown a mean
maximal deviation of only 1 mm from
the intended targets. Nonetheless,
the role of Stereotactic radiosurgery
in the treatment of PD remains highly
controversial at present.
Transplantation
The methods described above so
far aim at altering the physical
manifestations of the disease without
affecting its natural history. Cell
transplantation, on the other hand, is
an alternative approach to treat PD by
replacing the dopaminergic neurones
wi th in the basal ganglion, and
thereby reversing or compensating
for the on-going neuro-degenerative
process. Results of autologous adult
adrenal medulla cell implants were
ini t ial ly encouraging.2 0 Further
controlled clinical trials, however,
failed to demonstrate any systematic
or lasting benefit. Graft function and
survival was found to be poor and the
t e c h n i q u e h a s b e e n l a r g e l y
abandoned.
Fetal neurones, on the other
hand, are able to survive well ,
reinnervate and establish synaptic
contacts with host neurones, and
sustain many of the morphological
and funct ional characteristics of
normal nigral neurones following
grafting into a patient with PD.21 In
fetal mesencephalic transplantation,
the rostral mid-brain containing
dopaminergic neurones is harvested
f r o m f e t u s e s o b t a i n e d f r o m
therapeutic abortions (6 to 8 weeks
gestation). The graft is then injected
into the desired brain location of the
host stereotactically (e.g. caudate
nucleus). Usually, nerve cells from
3 to 4 "donors" are required for each
recipient. To date, more than 200 of
patients with PD have been treated
with this method and significant
improvement in akinetic symptoms
and motor f u n c t i o n has been
observed.22-23 The exact mechanism
at work is unknown but the clinical
effects are often delayed in onset and
progressive with time, signifying that
actual reinnervation by the graft
neurones may play an important
role.24 The technique is a promising
new strategy for the treatment of PD
despite the potential problems with
infection and graft rejection. In
addition, one cannot overlook the
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1. Levodopa is the most efficacious form of symptomatic treatment but is associated with disabling side-effects and
reduction in efficacy after prolonged administration.
2. Thalamotomy is most effective at relieving contralateral tremor whereas rigidity and bradykinesia respond best to
treatment at the globus pallidus.
3. The subthalamic nucleus is a promising new treatment target.
4. Chronic stimulation has the advantage of being programmable but is more costly and labour-intensive than ablative
therapy.
5. The role of gamma-knife is highly controversial.
6. Cell transplant may offer a cure in the future by actually altering the natural history of the disease.
associated ethical, legal and religious
i s sues w h e n i m p l e m e n t i n g t h i s
treatment.
Conclusion
Surgery is a promising approach
for the t r e a t m e n t of PD. I t i s
currently an useful adjunct to medical
therapy, and may even in the future
stand as an alternative. Patient and
treatment method selection based on
symptomatology and surgical risk
factors is of pr imary importance.
Educat ion for both pa t i en t s and
medical personnel dealing with the
disease is c ruc ia l in b r i n g i n g the
techniques to their deserved level of
acceptance and application. •
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Public Education Committee News
In order to present a clear image to the public on "What is a Family Physician?" and "What is Family
Medicine?", our College would like to hold a CONTEST on writing up the "DEFINITION of FAMILY
MEDICINE" in BOTH English and Chinese.
For interested parties, please submit your entry before 31 March. 1999 to
^v
Chairman, Public Education Committee
The Hong Kong College of Family Physicians
Room 701, 7/Fv Hong Kong Academy of Medicine Jockey Club Building,
99 Wong Chuk Hang Road, Aberdeen, Hong Kong.
(Please mark [Contest on 'Definition of Family Medicine'] on the envelope for our easy reference.)
Winner of the contest will be presented with a cash award of HK$2,000 which is generously donated
by our President. The winning entry will be published in The Hong Kong Practitioner.
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